×
For best experience we recommend to activate Javascript in your browser.
HLA-DRA antibody (AA 27-216)
The Rabbit Polyclonal anti-HLA-DRA antibody has been validated for WB and IHC. It is suitable to detect HLA-DRA in samples from Human.
Quick Overview for HLA-DRA antibody (AA 27-216) (ABIN7619264)
Target
See all HLA-DRA Antibodies
HLA-DRA
(HLA Class II DR alpha (HLA-DRA))
Reactivity
All reactivities for HLA-DRA antibodies
Human
Host
All hosts for HLA-DRA antibodies
Rabbit
Clonality
All clonalities for HLA-DRA antibodies
Polyclonal
Conjugate
All conjugates for HLA-DRA antibodies
This HLA-DRA antibody is un-conjugated
Application
All applications for HLA-DRA antibodies
Western Blotting (WB), Immunohistochemistry (IHC)
Product Details anti-HLA-DRA Antibody
(hide)
Binding Specificity
All epitopes for HLA-DRA antibodies
AA 27-216
Purpose
HLA Class II Histocompatibility Antigen, DR Alpha Chain (HLA-DRA) Polyclonal Antibody
Sequence
Lys27~Glu216
Characteristics
The HLA Class II Histocompatibility Antigen, DR Alpha Chain (HLA-DRA) Polyclonal Antibody (Species: Human) has been validated for the following applications: WB, IHC.
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Concentration
0.5 mg/mL
Buffer
0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol
Preservative
ProClin
Precaution of Use
This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Storage Comment
2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
Expiry Date
12 months
Target Details for HLA-DRA
(hide)
Target
HLA-DRA
(HLA Class II DR alpha (HLA-DRA))
Alternative Name
HLA-DRA
Gene ID
3122
UniProt
P01903
Pathways
TCR Signaling , CXCR4-mediated Signaling Events , Human Leukocyte Antigen (HLA) in Adaptive Immune Response
Recently viewed
(hide)
Chat with us , powered by LiveChat